Long-term survival achieved by repeated administration of ramucirumab after drug holidays due to proteinuria in recurrent gastric cancer
Abstract Background The prognosis of recurrent and unresectable gastric cancer remains poor despite the development of multidisciplinary treatments. Ramucirumab (RAM) has been proven effective against unresectable or recurrent gastric cancer. However, its administration is often discontinued because...
Saved in:
Main Authors: | Naoyuki Uehata, Keita Kouzu, Hironori Tsujimoto, Hidekazu Sugasawa, Kotaro Wakamatsu, Yoji Kishi, Hideki Ueno |
---|---|
Format: | Article |
Language: | English |
Published: |
Japan Surgical Society
2021-04-01
|
Series: | Surgical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40792-021-01185-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A case of ramucirumab-related gastrointestinal perforation in gastric cancer with small bowel metastasis
by: Shinya Urakawa, et al.
Published: (2017-12-01) -
Treatment of proteinuria with lercanidipine associated with reninangiotensin axis-blocking drugs
by: N. R. Robles, et al.
Published: (2011-06-01) -
Laboratory Assessment of Thyroid Function in Patients with Proteinuria
by: Irena Gencheva-Angelova, et al.
Published: (2018-03-01) -
RELATIONSHIP BETWEEN LEUKOCYTE COUNT AND PROTEINURIA IN COVID-19 PATIENTS
by: Anggar Setiorini, et al.
Published: (2023-01-01) -
Delayed severe hemothorax caused by a staple line of a bullectomy performed 11 years earlier
by: Takashi Yamashita, et al.
Published: (2023-11-01)